Indication
Alcaptonuria
Alcaptonuria (also spelled alkaptonuria) is a rare autosomal recessive inborn error of metabolism caused by a deficiency in the hepatic enzyme homogentisate 1,2-dioxygenase, which disrupts the normal catabolism of phenylalanine and tyrosine. Read more about Alcaptonuria
9 drugs 7 manufacturers
Drugs that treat it
Common Alcaptonuria therapies.
ORFADIN (nitisinone)
NITYR (nitisinone)
NITISINONE
NITISINONE
NITISINONE
NITISINONE
NITISINONE
HARLIKU (nitisinone)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAlcaptonuria (also spelled alkaptonuria) is a rare autosomal recessive inborn error of metabolism caused by a deficiency in the hepatic enzyme homogentisate 1,2-dioxygenase, which disrupts the normal catabolism of phenylalanine and tyrosine.
This enzymatic defect leads to the systemic accumulation and urinary excretion of homogentisic acid, which oxidizes into dark benzoquinone acetic acid polymers.
Clinically, it manifests in infancy with urine that darkens upon air exposure, followed by adult-onset ochronosis—characterized by bluish-black pigment deposition in connective tissues.
Over time, this pigment deposition leads to severe, early-onset ochronotic osteoarthropathy of the spine and weight-bearing joints, as well as complications such as heart valve calcification, nephrolithiasis, and tendon rupture.
- medlineplus.gov
Alcaptonuria (also spelled alkaptonuria) is a rare autosomal recessive inborn error of metabolism caused by a deficiency in the hepatic enzyme homogentisate 1,2-dioxygenase, which disrupts the normal catabolism of phenylalanine and tyrosine Over time, this pigment deposition leads to severe, early-onset ochronotic osteoarthropathy of the spine and weight-bearing joints, as well as complications such as heart valve calcification, nephrolithiasis, and tendon rupture
- nih.gov
Alcaptonuria (also spelled alkaptonuria) is a rare autosomal recessive inborn error of metabolism caused by a deficiency in the hepatic enzyme homogentisate 1,2-dioxygenase, which disrupts the normal catabolism of phenylalanine and tyrosine This enzymatic defect leads to the systemic accumulation and urinary excretion of homogentisic acid, which oxidizes into dark benzoquinone acetic acid polymers
- news-medical.net
This enzymatic defect leads to the systemic accumulation and urinary excretion of homogentisic acid, which oxidizes into dark benzoquinone acetic acid polymers Clinically, it manifests in infancy with urine that darkens upon air exposure, followed by adult-onset ochronosis—characterized by bluish-black pigment deposition in connective tissues
- medlineplus.gov
Clinically, it manifests in infancy with urine that darkens upon air exposure, followed by adult-onset ochronosis—characterized by bluish-black pigment deposition in connective tissues
- tandfonline.com
Over time, this pigment deposition leads to severe, early-onset ochronotic osteoarthropathy of the spine and weight-bearing joints, as well as complications such as heart valve calcification, nephrolithiasis, and tendon rupture
- orpha.net
Over time, this pigment deposition leads to severe, early-onset ochronotic osteoarthropathy of the spine and weight-bearing joints, as well as complications such as heart valve calcification, nephrolithiasis, and tendon rupture
Personalize your experience
Follow Alcaptonuria and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.